Resveratrol inhibition of Propionibacterium acnes

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 6, 2007, Pages 1182-1184

  Docherty, John J ^a   McEwen, Heather A ^a   Sweet, Thomas J ^a   Bailey, Erin ^a   Booth, Tristan D ^b  

^a Northeast Ohio Medical University   (United States)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

Antimicrobial activity; Drug development; Human disease

Indexed keywords

BENZOYL PEROXIDE; ERYTHROMYCIN; PICEATANNOL; RESVERATROL; STILBENE DERIVATIVE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; IC 50; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROPIONIBACTERIUM ACNES;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOYL PEROXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROMYCIN; KERATOLYTIC AGENTS; MICROBIAL SENSITIVITY TESTS; PROPIONIBACTERIUM ACNES; STILBENES;

EID: 34447517642     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm099     Document Type: Article

References (8)

1. Hain R, Bieseler B, Kindl H et al. Expression of a stilbene synthase gone in Nicotiana tabacum results in synthesis of the phytoalexin resveratrol. Plant Mol Biol 1990; 15: 325-36.
2. Donnelly LE, Newton R, Kennedy GE et al. Anti-inflammatory effects of resveratrol in lung epithelial cells: Molecular mechanisms. Am J Physio Lung Cell Mol Physiol 2004; 287: L774-83.
3. Docherty JJ, Fu MM, Tsai M. Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis. J Antimicrob Chemother 2001; 47: 243-4.
4. Mahady GB, Pendland SL. Resveratrol inhibits growth of Helicobacter pylori in vitro. Am J Gastroenterol 2000; 95: 1849.
5. Chan MM. Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin. Biochem Pharmacol 2002; 63: 99-104.
6. Wang WB, Lai HC, Hsueh PR et al. Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol. J Med Microbiol 2006; 55: 1313-21.
7. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria - Fifth Edition: Approved Standard M11-A6. NCCLS, Wayne, PA, USA, 2000.
8. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antibacterial Agents: Approved Guideline M26-A. NCCLS, Villanova, PA, USA, 1999.